Astragalus

Astragalus is a traditional medicinal herb derived from the root of Astragalus membranaceus, used for its immunomodulatory, adaptogenic, and cardioprotective properties.

Overview

Astragalus membranaceus (also known as Huang Qi) is one of the most widely used herbs in traditional Chinese medicine, with a documented history spanning over two thousand years. The root contains a complex array of bioactive compounds including polysaccharides, saponins (such as astragalosides), and flavonoids, which collectively contribute to its pharmacological profile. It is traditionally classified as a qi-tonifying herb and has been used to support immune function, energy, and overall vitality.

Modern research has focused on the immunomodulatory effects of astragalus, with studies indicating it can enhance natural killer cell activity, stimulate macrophage function, and promote T-cell proliferation. Clinical investigations have explored its potential as an adjunctive therapy in cancer treatment, where it may help mitigate chemotherapy-induced immunosuppression. The herb has also been studied for cardioprotective effects, including improvement of left ventricular function in patients with heart failure, and for renoprotective activity in the context of diabetic nephropathy.

Astragalus root preparations are available in numerous forms including dried root slices, powdered extracts, and standardized capsules. It is generally considered safe, though it may interact with immunosuppressive medications due to its immune-stimulating properties. Quality and potency can vary significantly among commercial products, making standardized extracts preferable for research and therapeutic applications.

Mechanism of Action

Multi-Component Pharmacology

Astragalus (Astragalus membranaceus) root contains three principal bioactive classes: astragalosides (cycloartane triterpenoid saponins, especially astragaloside IV), astragalus polysaccharides (APS, heteroglycans), and isoflavonoids (formononetin, calycosin). These constituents act synergistically across immune, cardiovascular, and metabolic pathways (PMID: 22981502).

Immune System Enhancement

Astragalus polysaccharides bind to Toll-like receptor 4 (TLR4) on macrophages and dendritic cells, activating the MyD88/NF-kB and MAPK signaling cascades. This stimulates phagocytosis, antigen presentation, and secretion of IL-2, IL-12, and IFN-gamma — shifting immunity toward a Th1 response. APS also promotes T cell proliferation and enhances NK cell cytotoxicity through upregulation of NKG2D and perforin expression (PMID: 20041385).

Telomere Protection & Anti-Aging

Astragaloside IV activates telomerase (hTERT) expression via MAPK/ERK signaling, supporting telomere length maintenance in lymphocytes and stem cells. Cycloastragenol, a sapogenin metabolite, has been commercialized as the telomerase activator TA-65. This mechanism extends immune cell replicative capacity and may slow immunosenescence (PMID: 21426483).

Cardiovascular & Cardioprotective Mechanisms

Astragaloside IV activates PI3K/Akt and eNOS pathways, enhancing nitric oxide production and vasodilation. It protects cardiomyocytes from ischemia-reperfusion injury by stabilizing mitochondrial membrane potential, reducing caspase activation, and upregulating Bcl-2/Bax ratio. Formononetin also activates PPAR-gamma, improving lipid metabolism (PMID: 27174435).

Nrf2 Antioxidant & Anti-Fibrotic Effects

Astragalus components activate Keap1-Nrf2-ARE signaling, upregulating HO-1, SOD, and GPx. Astragaloside IV inhibits TGF-beta1/Smad signaling, reducing collagen deposition and myofibroblast activation — mechanisms investigated for renal and pulmonary fibrosis (PMID: 25267474).

Reconstitution Calculator

Reconstitution Calculator

Calculate your peptide dosing

Draw Volume
0.100mL
Syringe Units
10units
Concentration
2,500mcg/mL
Doses / Vial
20doses
Vial Total
5mg
Waste / Vial
0mcg
Syringe Cap.
100units · 1mL
How to reconstitute
Gather & prepare
1/6Gather & prepare

Set up a clean workspace with all supplies ready.

1.Wash hands thoroughly, put on disposable gloves
2.Your 5mg peptide vial (lyophilized powder)
3.Bacteriostatic water (you'll need 2mL)
4.A 3–5mL syringe with 21–25 gauge needle for reconstitution
5.Alcohol swabs (70% isopropyl)
Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials. Sterile water is only safe for single-use.
Supply Planner

7x / week for weeks

·
40%
2vials
28 doses20 days/vial12 leftover
Cost Breakdown
Vial price
$0.00per dose
$0.00 /week$0 /month
Store 2-8°C30 day shelf lifeSwirl gentlyFor research purposes only

Research

Reported Effects

Subtle Effects:: Most users report mild, gradual benefits rather than immediate or dramatic changes, leading some to question its value. Synergistic Use:: Appears most effective when combined with other supplements (quercetin, adaptogens, rhodiola) rather than standalone. Individual Variation:: Effectiveness varies considerably between users, with some reporting no noticeable benefits even after months of use. Bioavailability Enhancement:: Research suggests Astragalus polysaccharides may enhance absorption of other compounds like quercetin by 68-fold

  • Most users report mild, gradual benefits rather than immediate or dramatic changes, leading some to question its value
  • Appears most effective when combined with other supplements (quercetin, adaptogens, rhodiola) rather than standalone
  • Effectiveness varies considerably between users, with some reporting no noticeable benefits even after months of use
  • Research suggests Astragalus polysaccharides may enhance absorption of other compounds like quercetin by 68-fold

Safety Profile

Safety Profile: Astragalus (Astragalus membranaceus / Huang Qi)

Common Side Effects

  • Mild gastrointestinal symptoms: bloating, loose stools, diarrhea (dose-related)
  • Mild allergic reactions: skin rash, itching
  • Dizziness and fatigue at higher doses
  • Nasal dryness with prolonged use (traditional Chinese medicine observation)
  • Mild diuretic effect (increased urination)

Serious Adverse Effects

  • Immune overstimulation: Astragalus polysaccharides and saponins (astragalosides) are potent immunomodulators. May exacerbate autoimmune conditions including lupus, rheumatoid arthritis, multiple sclerosis, and Crohn's disease
  • Potential interference with immunosuppressive therapy; documented reduction in cyclosporine efficacy in animal models
  • Hypoglycemia: Astragalus has demonstrated blood glucose-lowering effects in diabetic models; risk of hypoglycemia with concurrent antidiabetic therapy
  • Bleeding: Astragaloside IV has antiplatelet properties; may increase bleeding risk
  • Herb-contamination risk: Some Astragalus species (A. lentiginosus, A. mollissimus) are toxic selenium accumulators ("locoweed"); quality sourcing critical
  • Potential drug-herb interactions with transplant immunosuppression (see below)

Contraindications

  • Active autoimmune diseases (SLE, RA, MS, IBD, Type 1 diabetes) unless under direct medical supervision
  • Organ transplant recipients on immunosuppressive regimens
  • Known allergy to Astragalus or Fabaceae (legume) family plants
  • Acute infection with fever (traditional Chinese medicine contraindication; may "trap" pathogen)
  • Active bleeding or hemorrhagic conditions
  • Pre-surgery: Discontinue at least 2 weeks before scheduled procedures

Drug Interactions

  • Immunosuppressants (cyclosporine, tacrolimus, mycophenolate, azathioprine): Astragalus may directly counteract immunosuppression; potentially dangerous in transplant patients. Well-documented in pharmacological studies
  • Anticoagulants/Antiplatelets (warfarin, heparin, clopidogrel, aspirin): Additive bleeding risk; monitor INR with warfarin
  • Antidiabetic medications (insulin, metformin, sulfonylureas): Enhanced hypoglycemic effect; glucose monitoring required
  • Lithium: Diuretic properties of astragalus may reduce lithium clearance, increasing levels and toxicity risk
  • Antihypertensives: Mild blood pressure-lowering effect may be additive
  • Cyclophosphamide: Complex interaction; astragalus may reduce cyclophosphamide-induced immunosuppression (studied in oncology settings)
  • CYP substrates: Limited CYP interaction data; some in vitro inhibition of CYP2C19 reported

Population-Specific Considerations

  • Pregnancy: Traditionally used in Chinese medicine during pregnancy for "Qi deficiency," but modern safety data insufficient. Some animal studies suggest uterotonic effects. European and American guidelines recommend avoiding during pregnancy. Not recommended during breastfeeding without medical supervision
  • Pediatric: Used traditionally in children for immune support in Chinese medicine. Limited Western clinical trial data in pediatric populations. Standard doses (3-5 mg/kg) generally well tolerated in children >6 years in small studies. Avoid in children with autoimmune conditions
  • Elderly: Generally well tolerated and potentially beneficial for age-related immune decline. Clinical trials in elderly populations (cardiovascular protection) have shown acceptable safety profiles. Adjust dose for renal impairment. Monitor for drug interactions with cardiovascular and diabetic medications

Pharmacokinetic Profile

Astragalus — Pharmacokinetic Curve

Subcutaneous
0%25%50%75%100%0m5.5h10.9h16.3h21.8h27.3hTimeConcentration (% peak)T_max 1.6hT_1/2 5.5h
Half-life: 5.5hT_max: 1.5hDuration shown: 27.3h

Quick Start

Typical Dose
550-1000mg daily is commonly used, often from root extract capsules

Safety Profile

Common Side Effects

  • Generally Well-Tolerated:: Most users report no significant side effects, making it one of the safer herbs in supplement stacks
  • Mild GI Effects:: Some reports of mild gastrointestinal irritation when taken on empty stomach or at higher doses
  • Quality Concerns:: Users note that cheaper brands may contain contaminants or inactive ingredients, emphasizing need for reputable sources
  • Minimal Interactions:: Few reported interactions with other supplements, though careful stacking still recommended

References (8)

  1. [6]
    Astragalus polysaccharide alleviates mastitis disrupted by Staphylococcus aureus infection by regulating gut microbiota and SCFAs metabolism

    APS treatment reduced inflammation and oxidative stress while protecting tissue barriers during bacterial infection by regulating gut microbiota and short-chain fatty acid metabolism, highlighting systemic immune benefits through gut modulation.

  2. [1]
    A Natural Astragalus-Based Nutritional Supplement Lengthens Telomeres in a Middle-Aged Population: A Randomized, Double-Blind, Placebo-Controlled Study

    A 6-month randomized controlled trial found that Astragalus-based supplementation significantly lengthened telomeres in healthy middle-aged adults (mean age 56.1 years), suggesting potential anti-aging effects through genomic integrity maintenance.

  3. [2]
    Structural characterization and anti-inflammatory activity of polysaccharides from Astragalus membranaceus

    Research identified two distinct polysaccharides (APS-A1 and APS-B1) from Astragalus with characterized molecular structures and demonstrated anti-inflammatory properties, providing mechanistic understanding of its therapeutic effects.

  4. [3]
    Effects of Dietary Astragalus Polysaccharide Supplementation on the Th17/Treg Balance and the Gut Microbiota of Broiler Chickens Challenged With Necrotic Enteritis

    Astragalus polysaccharide (200 ppm) supplementation improved immune balance, reduced inflammatory markers, and modulated gut microbiota composition in an infection challenge model, demonstrating immunomodulatory and gut health benefits.

  5. [4]
    Astragalus polysaccharide (APS) supplement in beagle dogs after castration: Effects on the haematology and serum chemistry profiles, immune response, and oxidative stress status

    An 8-week study with APS supplementation (400-800 mg/kg) showed improvements in hematology profiles, immune response markers, and oxidative stress status in dogs post-surgery, supporting its role in enhancing natural defense mechanisms.

  6. [7]
    Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice

    Study demonstrated that Astragalus-derived polysaccharides can modulate specific gut bacteria to produce beneficial metabolites, showing therapeutic potential for metabolic conditions like NAFLD through microbiome regulation.

  7. [8]
    Astragalus species: Insights on its chemical composition toward pharmacological applications

    Comprehensive review detailing the chemical composition of Astragalus species including polysaccharides, saponins, and flavonoids, providing scientific basis for its diverse pharmacological applications in traditional and modern medicine.

  8. [5]
    Oral Astragalus polysaccharide alleviates adenine-induced kidney injury by regulating gut microbiota-short-chain fatty acids-kidney G protein-coupled receptors axis

    Astragalus polysaccharide protected against chronic kidney disease by modulating gut microbiota composition, increasing beneficial bacteria and short-chain fatty acid production, demonstrating a gut-kidney axis mechanism of action.

Updated 2026-03-08Sources: peptidebay

On this page